The PediCAP consortium consists of 14 partners
Led by Penta, the PediCAP project builds on long-standing collaborations between experts in paediatric clinical trials and clinical partners from Europe and sub-Saharan Africa. The PediCAP consortium will build on this expertise, aiming to engage a younger generation of paediatricians and scientists who could become the future leaders in paediatric antibiotic clinical trials, providing the evidence for future national and global optimal prescribing guidelines.
Universidade Eduardo Mondlane (UEM)
3453 Avenida Julius Nyerere, Maputo, Mozambique
Global Antibiotic Research and Development Programme (GARDP)
15 Chemin Camille-Vidart, 1202 Geneva, Switzerland
University of Oxford (UOXF)
Oxford OX1 2JD, United Kingdom
Swiss Tropical and Public Health Institute (SWISS TPH)
Kreuzstrasse 2, 4123 Allschwil, Switzerland
University of Antwerp (UA)
Prinsstraat 13, 2000 Antwerpen, Belgium
University College of London (UCL)
Gower St, London WC1E 6BT, United Kingadom
Kwa-Zulu-Natal Research Institute for TB-HIV (AHRI)
Suite Z319 3rd Floor Ddmri Building, 719 Umbilo Road, Congella, Durban, 4001, South Africa
University Teaching Hospital Zambia (UTH)
High Cost, Lusaka, Zambia
University of Zimbabwe College of Health Sciences Clinical Trial Research Centre (UZCHS)
52RV+556, Harare, Zimbabwe
Makerere University (MU)
7062 University Rd, Kampala, Uganda
University of Cape Town (UCT)
Rondebosch, Cape Town, 7700, South Africa
Wits Health Consortium (WHC)
31 Princess of Wales Terrace, Parktown, Johannesburg, 2193
St George’s University
Penta
Corso Stati Uniti 4, 35127 Padova